Gurnet Point Capital
PE
INVESTOR TYPE
Active
STATUS
9
PROFESSIONALS
15
INVESTMENTS
10
PORTFOLIO
1
EXITS
Description
Founded in 2013, Gurnet Point Capital is a private equity firm headquartered in Cambridge, Massachusetts with an additional office in San Francisco, California. The firm seeks to invest in the life science, medical technologies, and healthcare sectors.
Website
Investor Status
Actively Seeking New Investments
Year Founded
2013
Primary Investor Type
PE/Buyout
Other Investor Types
Growth/Expansion
Primary Office
- 55 Cambridge Parkway
- Suite 401
- Cambridge, MA 02142
- United States
+1 (617) 000-0000
Gurnet Point Capital Investments (15)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| 000000 000000 | 26-Sep-2019 | 00000 00000 | 0000 | Food Products | Generating Revenue | 00000000000 0000000000 |
| 00000000 (000 0000 | 04-Sep-2019 | 0000000000 | 0000 | Other Healthcare | Generating Revenue | |
| 000000 00000000000 | 27-Nov-2018 | 0000000000 | 00000 | Drug Delivery | Profitable | 00000000000 0000000000 |
| 00000000 (00000000 | 03-Oct-2018 | 0000000000 | Other Pharmaceuticals and Biotechnology | 000000 000000 | ||
| Novartis (Worldwide Rights to LYS228, IID572 and MAK181) | 03-Oct-2018 | Buyout/LBO | Buildings and Property | 000000 000000 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Gurnet Point Capital’s full profile, request a free trial.
Gurnet Point Capital Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000000 | 09-May-2019 | 000 | 000.00 | Completed |
|
Gurnet Point Capital Team (14)
5 Former Team Members
You’re viewing 5 of 14 team members. Get the full list »